Dr. Brian C. Boulmay
Claim this profileUniversity Medical Center New Orleans
Area of expertise
Lung Cancer
Brian C. Boulmay has run 9 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Brian C. Boulmay has run 7 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Medical Center New Orleans
Louisiana State University Health Science Center
Clinical Trials Brian C. Boulmay is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting
2 awards
Phase 3
28 criteria
Radiation Therapy + Cisplatin
for Head and Neck Cancer
This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting
1 award
Phase 2
19 criteria
More about Brian C. Boulmay
Clinical Trial Related
6 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Brian C. Boulmay has experience with
- Cisplatin
- Carboplatin
- Pembrolizumab
- Pemetrexed
- Intensity-Modulated Radiation Therapy
- Atezolizumab
Breakdown of trials Brian C. Boulmay has run
Lung Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian C. Boulmay specialize in?
Brian C. Boulmay focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage IV.
Is Brian C. Boulmay currently recruiting for clinical trials?
Yes, Brian C. Boulmay is currently recruiting for 8 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Brian C. Boulmay has studied deeply?
Yes, Brian C. Boulmay has studied treatments such as Cisplatin, Carboplatin, Pembrolizumab.
What is the best way to schedule an appointment with Brian C. Boulmay?
Apply for one of the trials that Brian C. Boulmay is conducting.
What is the office address of Brian C. Boulmay?
The office of Brian C. Boulmay is located at: University Medical Center New Orleans, New Orleans, Louisiana 70112 United States. This is the address for their practice at the University Medical Center New Orleans.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.